Dumin (Acetaminophen)

Quick links to important sections

Dumin (Acetaminophen)

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dumin (Acetaminophen)

Quick Facts

Property Description
Active ingredient Acetaminophen (Paracetamol)
Pharmacological class Analgesic and Antipyretic
Origin Synthetic (Para-aminophenol derivative)
Common purpose Symptomatic relief of pain and fever
Primary forms Oral tablets, capsule, suspension, intravenous solution

What is Dumin (Acetaminophen) and What Class Does it Belong To?

Dumin is a preparation containing the active substance Acetaminophen, known internationally as Paracetamol, which is fundamentally classified as an analgesic (pain reliever) and an antipyretic (fever reducer). The medication is categorized as a non-opioid analgesic, providing relief primarily through action in the central nervous system. Acetaminophen is a synthetic compound, chemically identified as N-acetyl-p-aminophenol and belonging to the para-aminophenol derivative class. Its established pharmacological profile makes it a key agent for relieving general discomfort and elevated body temperature.


Composition and Available Pharmaceutical Forms

The core active ingredient in the preparation is Acetaminophen, which is most often produced as a single-ingredient product and is widely available as an Over-the-Counter (OTC) medicine. To ensure broad accessibility, the active compound is formulated into several common dosage forms. These include solids like oral tablets and capsules, liquid preparations such as oral suspensions and solutions, and specific forms like rectal suppositories and sterile intravenous solutions. This diverse manufacturing allows the medication to be administered by different routes of administration, including oral, rectal, and parenteral.


The Core Benefit: Pain Relief and Fever Reduction

The general purpose of Acetaminophen is to offer symptomatic treatment by safely elevating the body's pain threshold and reducing fever. Its antipyretic function is achieved by influencing the brain's temperature-regulating center, the hypothalamus, which effectively helps the body normalize an abnormally high, fever-induced set point. Acetaminophen is consistently recognized on lists of essential medicines for its foundational roles as an analgesic and antipyretic. Its mechanism is predominantly central, distinguishing it from other pain relievers that primarily target peripheral inflammation at the site of injury.

Regulatory References

  1. WHO Essential Medicines Lists

What side effects are possible with Dumin (Acetaminophen)?

Possible side effects and safety information

Official Adverse Reaction Profile

The regulatory safety profile for Acetaminophen (Dumin) is primarily defined by the potential for hepatotoxicity (liver damage), which is the most critical constraint on use, particularly when exceeding the recommended daily maximum.

Adverse reactions are classified by official regulatory documents into categories based on frequency. Many of the severe systemic reactions are documented as Rare or Very Rare.


Systemic and Serious Reactions

The most clinically significant serious adverse reactions documented in regulatory sources include Acute Liver Failure, which may lead to liver transplantation or death, and Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). These systemic effects are formally grouped into Hepatobiliary disorders, Skin and subcutaneous tissue disorders, and Immune system disorders.

Other rare, but documented, effects involve the Blood and lymphatic system disorders, including conditions like thrombocytopenia and agranulocytosis.


Safety Constraints and Special Populations

Official labels impose strict limitations on use. The medicine is generally contraindicated in patients with severe hepatic impairment or severe active liver disease due to the increased risk of liver toxicity. Safety concerns also apply to individuals who are chronic alcohol users or those with malnutrition.

The risk of nephropathy (kidney damage) and increased liver susceptibility are specifically associated with prolonged, excessive duration of use that exceeds established safety limits, a pattern documented in regulatory texts.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Acetaminophen (Dumin), as detailed in regulatory documents, centers on the risk of delayed hepatotoxicity (severe liver damage), which can be life-threatening.

Overdose manifestations initially include non-specific symptoms such as nausea, vomiting, diaphoresis (sweating), and abdominal pain. However, the absence of these early signs does not exclude the risk of serious liver damage that develops later. Later, severe outcomes documented in official labeling include hepatic necrosis (liver tissue death), hepatic failure, and secondary issues like metabolic acidosis and acute renal tubular necrosis.

Urgent medical attention is required immediately after a suspected or known overdose, even if the patient feels well, due to the critical risk of progressive liver injury. Regulatory authorities mandate seeking immediate medical help or contacting a poison control center right away.

Management in overdose cases is time-sensitive. The specific antidote, N-acetylcysteine (NAC), is required and most effective when administered promptly. Protocols require plasma concentration monitoring and continuous hospital observation to assess risk and guide treatment. Overdose risk is stated to be greater in patients with pre-existing conditions like non-cirrhotic alcoholic liver disease.

Therapeutic Uses of Dumin (Acetaminophen)

What Dumin (Acetaminophen) Treats: Main Uses and Benefits

Dumin, containing acetaminophen, is commonly used for symptomatic relief in situations involving certain distressing symptoms. The medication is generally used to help with symptoms related to two main areas: pain and fever.

Acetaminophen is commonly used to help with supportive symptom management for mild to moderate pain that creates noticeable physiological strain. It helps address symptom clusters like headache, general muscular aches, and backache, as well as focused, episodic pain such as toothache and menstrual cramps. As a relevant therapeutic benefit, it contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability.

It is also applied across domains where additional symptomatic support is needed for symptoms that create noticeable physiological strain, such as elevated core body temperature (fever) associated with the common cold and flu. This application supports the easing of fever, helping patients cope more steadily with these distressing manifestations. This supportive use is commonly used in clinical settings for short-term postoperative care and may be part of symptomatic management in multimodal protocols.


Quick Fact: Relief for Headache and Fever

Regulatory References

  1. NIH MedlinePlus overview of Acetaminophen uses

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Dumin (Acetaminophen) — Official Regulatory Information

The eligibility profile for Dumin (Acetaminophen) is defined by mandatory exclusions and restrictions noted in governmental regulatory documents.


Eligibility Scope

Classification Population/Condition Regulatory Status
Absolute Contraindication Known hypersensitivity to acetaminophen or excipients; severe active liver disease or severe hepatic impairment. Use is formally prohibited.
Conditional Restriction Severe renal impairment (CrCl le 30 mL/min); chronic alcohol consumption (ge 3 drinks/day); malnutrition; G6PD deficiency. Use requires caution, potential dose adjustment, or interval extension.
Age-Related Eligibility Adults and adolescents are standard approved populations. Children are approved by weight. Use is not established for some formulations in pediatric patients younger than two years. Eligibility is based on age and weight thresholds.
Physiological Status Pregnancy and lactation are generally considered compatible. Use is permitted, but official guidance recommends the lowest effective dose for the shortest duration.

Connection to the Overall Eligibility Profile

Official regulatory documents define non-eligibility through absolute contraindications for patients with a history of allergy or severe liver disease. Eligibility is otherwise subject to conditional restrictions based on pre-existing organ function (hepatic and renal) and physiological factors such as chronic alcoholism or severe malnutrition. These restrictions structure who can use the medicine and under what limitations, as mandated by regulatory authorities like the FDA and EMA.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acetaminophen's official interaction profile is characterized by several pharmacologic and pharmacokinetic patterns documented in regulatory labeling. The primary focus of documented interactions involves changes to drug clearance and increased risk of specific toxicities.


Documented Exposure and Toxicity Risks

Co-administration with certain substances is officially documented to alter the exposure of Acetaminophen or increase toxicity risk:

  • Oral Anticoagulants (e.g., Warfarin): Prolonged daily use is officially documented to increase the International Normalized Ratio (INR), raising the risk of bleeding.
  • Hepatic Enzyme Inducers: Medicines such as phenytoin, carbamazepine, and rifampin may increase the formation of the toxic acetaminophen metabolite, which heightens the risk of hepatotoxicity.
  • Probenecid: Reduces the clearance of acetaminophen by inhibiting its excretion pathways, leading to an increase in plasma concentrations.
  • Isoniazid: Concurrent use is officially associated with a heightened risk of severe hepatotoxicity.

Timing and Substance Restrictions

Certain official restrictions govern the use of Acetaminophen with other substances:

  • Cholestyramine: Administration of this substance must be separated by at least one hour to prevent a reduction in the absorption of acetaminophen.
  • Chronic Alcohol Consumption: Regulatory warnings emphasize that chronic, heavy alcohol consumption significantly increases the risk of severe liver damage when taking acetaminophen, even at therapeutic doses.
  • Lamotrigine: Acetaminophen is documented to reduce the plasma concentration of this co-administered drug.

Interaction severity and resulting warnings may be heightened in patients with hepatic impairment, as stated in the prescribing information.

Mechanism of Action

Pharmacodynamic Mechanism: Central and Dual Action

Acetaminophen's mechanism of action involves primary activity within the Central Nervous System (CNS). Its antipyretic profile is achieved through the inhibition of cyclooxygenase (COX) enzymes, specifically COX-2 and COX-3 variants, predominantly in the hypothalamus. This enzymatic interference restricts the synthesis of pyretic signaling mediators, primarily prostaglandin E2 (PGE2), leading to the physiological consequence of antipyresis (lowered core temperature set point).

The analgesic action is dual. It results partly from central prostaglandin reduction and partly from its metabolite, AM404. This metabolite modulates neural signaling by inhibiting the reuptake of endogenous compounds within the endocannabinoid system and by desensitizing pain receptors like TRPV1. This mechanistic convergence increases the inhibitory influence within descending pain pathways. Acetaminophen's selectivity results in an action that acts predominantly on central pathways, demonstrating limited peripheral inhibition of COX enzymes due to local chemical constraints.

Dosage and Administration Information

The administration of Dumin, which contains acetaminophen (paracetamol), is officially approved for oral (tablet, liquid), rectal (suppository), and intravenous (IV) routes. The choice of route depends on the formulation available and the treatment setting, with the IV infusion typically restricted to institutional care.

Standard Dosage and Frequency

For adults weighing 50 kg or more, the standard oral single dose is generally 650 mg to 1,000 mg, intended to be taken every 4 to 6 hours as needed. Intravenous dosing for this population is either 1,000 mg every 6 hours or 650 mg every 4 hours. The minimum interval between doses is 4 hours for immediate-release forms, and the maximum total daily dose from all routes must not exceed 4,000 mg.

Special Administration Requirements

The medication may be taken with or without food. Specific formulations have administration constraints: for instance, extended-release tablets must be swallowed whole to maintain their functional integrity. The intravenous solution must be administered as a 15-minute infusion.

If a dose is missed, it should be taken immediately unless it is close to the next scheduled dose, in which case the missed dose is skipped to prevent exceeding the daily maximum.

Population-Specific Dosing Rules

Dose adjustments are established for certain populations. In cases of severe renal impairment, the dosing interval is required to be extended to 6 or 8 hours based on the degree of filtration rate decrease. For patients with hepatic impairment, the recommended total daily dose is typically reduced, often limited to 2,000 mg in many jurisdictions.

Recent Clinical Evidence

Research evidence / Overview of studies for Dumin (Acetaminophen)

Evidence for Pain and Symptom Relief

Research has explored the use of acetaminophen in conditions characterized by fluctuating or episodic manifestations, particularly general mild to moderate pain. The primary evidence base consists of numerous short-term Randomized Controlled Trials (RCTs) and systematic reviews focusing on adult populations. Studies monitored changes in patient-reported outcomes describing perceived discomfort, often using standardized pain scales over acute time intervals. For conditions involving chronic discomfort, such as osteoarthritis of the knee, follow-up durations were limited, and the evidence contributes to understanding short-term symptom patterns but not long-term outcomes.

Research Focused on Acute Migraine Headache

Acetaminophen was studied for its use in conditions associated with acute or disruptive episodes, specifically episodic migraine headache of moderate to severe intensity. Research examined outcomes describing episodic or acute changes, such as the achievement of pain-free status at the two-hour mark. Data show patterns related to headache response outcomes being measured in the populations studied. Systematic reviews described patterns where the documented pain-free response was observed to differ from some other therapies studied for acute migraine. Comparative evidence is lacking against all alternative first-line migraine therapies.

Evidence for Use in Fever Reduction (Antipyresis)

Acetaminophen was studied for its use in conditions involving periods of heightened symptoms, such as fever. Research examined outcomes related to systemic or functional imbalance, primarily the change in body temperature. The main outcomes studied were the observed change in body temperature and the documented time required to achieve afebrile status. Studies report how symptoms evolved; research describes patterns related to temperature measured across both children and adult participants. Data for long-term critical care outcomes remain insufficient.

Evidence in Short-Term Postoperative Care

Acetaminophen was evaluated in research exploring short-term symptom changes as part of multimodal pain management protocols used after various surgical procedures. Studies monitored patterns of total opioid consumption when acetaminophen was used in multimodal protocols. Research highlights changes measured during the study period for postoperative pain scores. However, results apply only to the populations studied, and findings were mixed regarding the consistency of the observed pattern on total opioid consumption across different types of surgery.

Evidence in Special Populations

Research has explored short-term symptom changes in specific populations, notably children (infants 6 months and older) and older adults. For both fever and acute pain, studies report how symptoms evolved in these observed populations. Research indicates there is limited specific information available for the use of this medicine in infants younger than six months of age.

Evidence Gaps and Areas of Uncertainty

Research highlights what is known—and what is still uncertain—about this medicine. A primary limitation is that follow-up durations were limited in many key studies. Comparative evidence is lacking for direct comparison against all alternative first-line therapies for both acute pain and migraine, as well as the uncertainty regarding the comparative value of intravenous versus oral formulations across all surgical procedures. Data for certain groups, such as very young infants, remain insufficient.

Key Studies & References

  1. Acetaminophen: Non-opioid analgesic and antipyretic agent utilized for treating pain and fever (StatPearls)
  2. Paracetamol (acetaminophen) - WHO Electronic Essential Medicines List (eEML)
  3. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults (Cochrane Review)
  4. Opioid-Sparing Effects of IV Acetaminophen for Patients Undergoing Surgery (Systematic Review Summary)
  5. Label: ACETAMINOPHEN tablet - Official US FDA DailyMed Monograph

Frequently Asked Questions (FAQ)

Common questions about Dumin (Acetaminophen) (FAQ)


Q: How quickly does Dumin usually start to work?

Official product information describes the typical onset of action for pain relief as occurring within one hour after taking the medicine by mouth. For the intravenous formulation, which is typically administered in a healthcare setting, the onset is noted to be much faster, often within 5 to 10 minutes.


Q: How long does the effect of Dumin typically last?

According to official sources, the duration of pain relief for a standard dose of the oral form of Dumin is typically documented as lasting approximately four to six hours.


Q: Can Dumin be taken with aspirin or ibuprofen?

Regulatory documents note that taking Dumin with other non-steroidal pain relievers is common. Regulatory warnings emphasize the need to monitor the total daily dose when combining pain relievers, as each medication’s safety information must be considered.


Q: Why is it important to check if other medicines contain acetaminophen when taking Dumin?

Health authorities, including the FDA, strongly caution that many over-the-counter and prescription products contain acetaminophen (Dumin). Taking more than one of these products at the same time can lead to an accidental overdose, which significantly increases the risk of severe liver damage or failure.


Q: What is the difference between Dumin and NSAIDs (like Ibuprofen) for pain relief?

Official classification states that Dumin is an analgesic and antipyretic. Unlike NSAIDs, which primarily work in the body’s periphery to address inflammation, Dumin’s main action for relieving pain is centered in the brain and spinal cord (central nervous system), resulting in limited peripheral anti-inflammatory effects.


Q: Can Dumin be used for menstrual pain?

Official indications for Dumin state that the medicine is used for the symptomatic relief of general mild to moderate pain. Menstrual pain is encompassed by the category of general mild to moderate pain, which is the official indication.


Q: Can Dumin be taken if I have a history of kidney problems?

Regulatory documents specify that individuals with severe renal (kidney) impairment may require an extended dosing interval to ensure the medicine is cleared from the body appropriately. This caution is in place to reduce the risk of adverse effects associated with severe kidney issues.


Q: How is Dumin described in official documents regarding its mechanism for reducing fever?

Official documents describe the antipyretic (fever-reducing) action as the medicine’s ability to inhibit certain enzymes (cyclooxygenase) predominantly in the brain's temperature-regulating center, the hypothalamus. This enzymatic interference restricts the synthesis of the chemical signals that cause the body's temperature set point to rise.


Q: Why is Dumin frequently included in cold and flu remedies?

Dumin is included in many cold and flu products because its official and approved purpose is the symptomatic relief of both general pain, such as body aches and headache, and the reduction of fever. These are common symptoms experienced during a cold or the flu.


Q: Can Dumin affect the results of a blood glucose test?

Official drug labels state that Dumin may interfere with certain laboratory tests. This includes specific methods used for the measurement of blood glucose (sugar) and uric acid.


Q: Can Dumin interact with herbal supplements?

Official drug labels primarily focus on known interactions with other prescription medicines. Official warnings regarding substances that affect liver enzymes are provided in labeling, and the overall daily dose remains a critical safety constraint.


Q: What are the signs of taking too much Dumin, as described by health authorities?

Health authorities state that symptoms of an acute overdose may initially include nausea, vomiting, loss of appetite, abdominal pain, and excessive sweating. These early signs can sometimes be delayed or mimic cold/flu symptoms and may progress to more severe symptoms like confusion or jaundice (yellowing of the skin/eyes) as liver damage develops.


Q: Is it possible to have an allergic reaction to Dumin?

Yes. Official documents list known hypersensitivity (an allergy) to acetaminophen as an absolute reason not to use the drug. Documented signs of a severe allergic reaction may include difficulty breathing, swelling, or a rash.


Q: Is Dumin appropriate for use by children?

Dumin is approved for use in children, with specific doses based on the child's weight or age. Regulatory documents note that the safety for some formulations is not established for infants younger than a certain age threshold, typically 6 months or 2 years, depending on the specific product label.


Q: What are the official guidelines regarding Dumin use and alcohol consumption?

Official warnings emphasize that the chronic, heavy consumption of alcohol significantly increases the risk of severe liver damage when taking Dumin, even when the medicine is used at recommended therapeutic doses. This is a crucial safety constraint found on regulatory labels.


Q: Does Dumin accumulate in the body over time?

Official pharmacokinetic descriptions indicate that the medicine is primarily metabolized by the liver and eliminated in the urine. Over 90% of the administered dose is typically cleared from the body within 24 hours, meaning it does not generally accumulate in the body with standard, correctly-spaced dosing.


Q: What is the purpose of the 'inactive ingredients' in a Dumin tablet?

Inactive ingredients are components that do not have a therapeutic effect themselves. Their purpose is essential to the product, helping to ensure the tablet has the correct size, color, and stability, and that the active ingredient is properly released and absorbed by the body.


Q: What are the main types of adverse reactions listed in regulatory documents for Dumin?

Official documents classify adverse reactions, with the main types being Hepatobiliary disorders (liver damage), Skin and subcutaneous tissue disorders (including severe cutaneous reactions), and Blood and lymphatic system disorders, which are all typically described as rare or very rare.


Q: Is it considered normal to not feel relief immediately after taking Dumin?

Yes, this is considered normal. Official sources describe the typical onset of action for pain relief as occurring within one hour after oral administration. Therefore, not feeling immediate relief is consistent with the drug’s expected pharmacological profile.


Q: Does Dumin carry a risk of dependence or addiction?

Dumin is officially classified as a non-opioid analgesic. In its standalone form, it does not carry a risk of physical dependence or addiction as described for controlled substances like opioids.


Q: Is Dumin safe to use for a toothache?

Official indications state Dumin is used for the symptomatic relief of general mild to moderate pain. Toothache is encompassed by the category of general mild to moderate pain, which is the official indication.


Q: What does official guidance say about Dumin use during breastfeeding?

Official guidance permits use at standard doses and describes that the amount of the drug that passes into breast milk is minimal and is not expected to cause adverse effects in the infant.


Q: Are there any specific groups of people for whom Dumin is strictly contraindicated?

Official labels state that Dumin is strictly contraindicated (formally prohibited) for individuals with a known history of hypersensitivity (allergy) to acetaminophen. It is also contraindicated for those with severe active liver disease or severe hepatic impairment.


Q: Can Dumin help with inflammation?

The official mechanism of action for Dumin is described as having a limited effect on the peripheral inhibition of pain pathways associated with inflammation. Its primary action is focused on relieving pain and reducing fever centrally, distinguishing it from drugs specifically indicated for peripheral inflammation.


Q: Does Dumin cause drowsiness or make you sleepy?

Drowsiness is generally not listed as a common side effect in official documents. Unlike many opioid or cold-remedy components, its primary mechanism is not associated with central nervous system sedation.


Q: Can taking Dumin affect liver test results?

Official documents state that high or excessive doses may potentially elevate liver enzyme test results. Additionally, Dumin may interfere with certain laboratory tests used to measure other blood components, such as uric acid and glucose.


Q: Is Dumin safe to take while pregnant, according to official sources?

Official guidance permits the use of Dumin during pregnancy and recommends the lowest effective dose for the shortest possible duration to manage symptoms.


Q: What types of food or drink might interact with Dumin?

Official guidance notes that the drug can be taken with or without food. However, official warnings emphasize the risk of severe liver damage when taken by individuals who chronically consume heavy amounts of alcohol. Separately, one documented drug interaction (Cholestyramine) requires separation from Dumin intake by at least one hour.


Q: Is Dumin effective for treating migraines or severe headaches?

Official documents describe research exploring the use of Dumin for acute migraine headache of moderate to severe intensity. The data show patterns related to achieving a pain-free status in the specific populations studied.


Q: What does official research say about the long-term use of Dumin?

Official regulatory documents indicate that research evidence for long-term use in conditions like chronic pain often has limited follow-up durations. It is emphasized that prolonged, excessive use beyond established safety limits is associated with an increased risk of kidney and liver damage.


Q: Can Dumin cause skin reactions as a side effect?

Yes. Official documents list severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as rare but documented systemic side effects.


Q: What are the differences in Dumin's effect when taken on an empty stomach versus with food?

While regulatory texts state Dumin may be taken with or without food, they generally do not describe differences in the drug's effect on pain or fever relief. Food intake can sometimes affect the speed of drug absorption, though this is not a universal clinical concern described in official patient labeling.

How should Dumin (Acetaminophen) be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory guidelines for Dumin (Acetaminophen) are designed to maintain product quality and safety until the labeled expiration date.

Storage Conditions

Requirement Details
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Protect from light, moisture, and excessive heat. Do not freeze.
Packaging Keep the medicine in its original, tightly closed container.
Child Safety Keep out of the reach of children. Packaging often includes child-resistant features.

Disposal Protocol

Expired or unused Dumin should be disposed of via a drug take-back program (e.g., pharmacy drop-off) if one is available. If a take-back program is not readily accessible, the medication may be discarded in the household trash. Before disposal, drugs must be mixed with an undesirable substance, such as dirt or used coffee grounds, and sealed in a plastic bag to prevent accidental ingestion and environmental contamination. Do not flush acetaminophen down the toilet or pour it down the sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dumin (Acetaminophen) found in:

A-Z Index: